Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints

Human Gene Therapy

Volumn 16, Issue 4, 2005, Pages 426-434

  Apparailly, F ^a   Khoury, M ^a   Vervoordeldonk, M J B ^b   Adriaansen, J ^b   Gicquel, E ^c   Perez, N ^c   Riviere, C ^c   Louis Plence, P ^a   Noel, D ^a   Danos, O ^c   Douar, A M ^c   Tak, P P ^b   Jorgensen, C ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c GÉNÉTHON   (France)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; PARVOVIRUS VECTOR; RECOMBINANT DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHEMOLUMINESCENCE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC TRANSDUCTION; LONG TERMINAL REPEAT; MALE; MOUSE; NONHUMAN; REPORTER GENE; RHEUMATOID ARTHRITIS; SEROTYPE; SYNOVIUM; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID;

ALKALINE PHOSPHATASE; ANIMALS; ARTHRITIS; BETA-GALACTOSIDASE; CELLS, CULTURED; DEPENDOVIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INJECTIONS, INTRA-ARTICULAR; JOINTS; KINETICS; MALE; MICE; MICE, INBRED DBA;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ESCHERICHIA COLI; MIRIDAE; MURINAE;

EID: 20844457135     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.426     Document Type: Article

References (40)

1. ALLEN, J.M., HALBERT, C.L., and MILLER, A.D. (2000). Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol. Ther. 1, 88-95.
2. APPARAILLY, F., MILLET, V., NOEL, D., JACQUET, C., SANY, J., and JORGENSEN, C. (2002). Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: Application to experimental arthritis. Hum. Gene Ther. 13, 1179-1188.
3. APPARAILLY, F., PLENCE, P., NOEL, D., and JORGENSEN, C. (2004). Recent advances for cell/gene therapy in rheumatoid arthritis. Curr. Med. Chem. 3, 119-138.
4. ARAI, Y., KUBO, T., FUSHIKI, S., MAZDA, O., NAKAI, H., IWAKI, Y., IMANISHI, J., and HIRASAWA, Y. (2000). Gene delivery to human chondrocytes by an adeno associated virus vector. J. Rheumatol. 27, 979-982.
5. BANTEL-SCHAAL, U., and ZUR HAUSEN, H. (1984). Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134, 52-63.
6. BANTEL-SCHAAL, U., DELIUS, H., SCHMIDT, R., and ZUR HAUSEN, H. (1999). Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J. Virol. 73, 939-947.
7. BANTEL-SCHAAL, U., HUB, B., and KARTENBECK, J. (2002). Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment. J. Virol. 76, 2340-2349.
8. BURGER, C., GORBATYUK, O.S., VELARDO, M.J., PEDEN, C.S., WILLIAMS, P., ZOLOTUKHIN, S., REIER, P.J., MANDEL, R.J., and MUZYCZKA, N. (2004). Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10, 302-317.
9. CHAN, J.M., VILLARREAL, G., JIN, W.W., STEPAN, T., BURSTEIN, H., and WAHL, S.M. (2002). Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol. Ther. 6, 727-736.
10. CHAO, H., LIU, Y., RABINOWITZ, J., LI, C., SAMULSKI, R.J., and WALSH, C.E. (2000). Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2, 619-623.
11. CHIORINI, J.A., KIM, F., YANG, L., and KOTIN, R.M. (1999). Cloning and characterization of adeno-associated virus type 5. J. Virol. 73, 1309-1319.
12. COTTARD, V., MULLEMAN, D., BOUILLE, P., MEZZINA, M., BOISSIER, M.C., and BESSIS, N. (2000). Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther. 7, 1930-1939.
13. DAVIDSON, B.L., STEIN, C.S., HETH, J.A., MARTINS, I., KOTIN, R.M., DERKSEN, T.A., ZABNER, J., GHODSI, A., and CHIORINI, J.A. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97, 3428-3432.
14. DU, L., KIDO, M., LEE, D.V., RABINOWITZ, J.E., SAMULSKI, R.J., JAMIESON, S.W., WEITZMAN, M.D., and THISTLETHWAITE, P.A. (2004). Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors. Mol. Ther. 10, 604-608.
15. GOATER, J., MULLER, R., KOLLIAS, G., FIRESTEIN, G.S., SANZ, I., O'KEEFE, R.J., and SCHWARZ, E.M. (2000). Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J. Rheumatol. 27, 983-989.
16. GRIMM, D., and KAY, M.A. (2003). From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3, 281-304.
17. GRIMM, D., KERN, A., RITTNER, K., and KLEINSCHMIDT, J.A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9, 2745-2760.
18. HILDINGER, M., AURICCHIO, A., GAO, G., WANG, L., CHIRMULE, N., and WILSON, J.M. (2001). Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75, 6199-6203.
19. LI, J., SAMULSKI, R.J., and XIAO, X. (1997). Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71, 5236-5243.
20. LOTERY, A.J., YANG, G.S., MULLINS, R.F., RUSSELL, S.R., SCHMIDT, M., STONE, E.M., LINDBLOOM, J.D., CHIORINI, J.A., KOTIN, R.M., and DAVIDSON, B.L. (2003). Adeno-associated virus type 5: Transduction efficiency and cell-type specificity in the primate retina. Hum. Gene Ther. 14, 1663-1671.
21. MADRY, H., CUCCHIARINI, M., TERWILLIGER, E.F., and TRIPPEL, S.B. (2003). Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum. Gene Ther. 14, 393-402.
22. MARINOVA-MUTAFCHIEVA, L., WILLIAMS, R.O., FUNA, K., MAINI, R.N., and ZVAIFLER, N.J. (2002). Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum. 46, 507-513.
23. MINGOZZI, F., SCHUTTRUMPF, J., ARRUDA, V.R., LIU, Y., LIU, Y.L., HIGH, K.A., XIAO, W., and HERZOG, R.W. (2002). Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector. J. Virol. 76, 10497-10502.
24. PAN, R.Y., XIAO, X., CHEN, S.L., LI, J., LIN, L.C., WANG, H.J., and TSAO, Y.P. (1999). Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J. Virol. 73, 3410-3417.
25. PAN, R.Y., CHEN, S.L., XIAO, X., LIU, D.W., PENG, H.J., and TSAO, Y.P. (2000). Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum. 43, 289-297.
26. QING, K., MAH, C., HANSEN, J., ZHOU, S., DWARKI, V., and SRIVASTAVA, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5, 71-77.
27. RABINOWITZ, J.E., ROLLING, F., LI, C., CONRATH, H., XIAO, W., XIAO, X., and SAMULSKI, R.J. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76, 791-801.
28. ROMMELAERE, J., and CORNELIS, J.J. (1991). Antineoplastic activity of parvoviruses. J. Virol. Methods 33, 233-251.
29. SALVETTI, A., OREVE, S., CHADEUF, G., FAVRE, D., CHEREL, Y., CHAMPION-ARNAUD, P., DAVID-AMELINE, J., and MOULLIER, P. (1998). Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9, 695-706.
30. SANDALON, Z., BRUCKHEIMER, E.M., LUSTIG, K.H., ROGERS, L.C., PELUSO, R.W., and BURSTEIN, H. (2004). Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J. Virol. 78, 12355-12365.
31. 5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82.
32. TAK, P.P., and BRESNIHAN, B. (2000). The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis. Arthritis Rheum. 43, 2619-2633.
33. TAKEDA, S., TAKAHASHI, M., MIZUKAMI, H., KOBAYASHI, E., TAKEUCHI, K., HAKAMATA, Y., KANEKO, T., YAMAMOTO, H., ITO, C., OZAWA, K., ISHIBASHI, K., MATSUZAKI, T., TAKATA, K., ASANO, Y., and KUSANO, E. (2004). Successful gene transfer using adeno-associated virus vectors into the kidney: Comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo. Nephron Exp. Nephrol. 96, e119-e126.
34. TOBIASCH, E., BURGUETE, T., KLEIN-BAUERNSCHMITT, P., HEILBRONN, R., and SCHLEHOFER, J.R. (1998). Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J. Virol. Methods 71, 17-25.
35. WANG, A.Y., PENG, P.D., EHRHARDT, A., STORM, T.A., and KAY, M.A. (2004). Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. Hum. Gene Ther. 15, 405-413.
36. WATANABE, S., IMAGAWA, T., BOIVIN, G.P., GAO, G., WILSON, J.M., and HIRSCH, R. (2000). Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. Mol. Ther. 2, 147-152.
37. WEBER, M., RABINOWITZ, J., PROVOST, N., CONRATH, H., FOLLIOT, S., BRIOT, D., CHEREL, Y., CHENUAUD, P., SAMULSKI, J., MOULLIER, P., and ROLLING, F. (2003). Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Mol. Ther. 7, 774-781.
38. XIAO, X., LI, J., and SAMULSKI, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.
39. ZABNER, J., SEILER, M., WALTERS, R., KOTIN, R.M., FULGERAS, W., DAVIDSON, B.L., and CHIORINI, J.A. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74, 3852-3858.
40. ZHANG, H.G., XIE, J., YANG, P., WANG, Y., XU, L., LIU, D., HSU, H.C., ZHOU, T., EDWARDS, C.K., III, and MOUNTZ, J.D. (2000). Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor α and reduces arthritis. Hum. Gene Ther. 11, 2431-2442.